+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment



Chronic Recurrent Multifocal Osteomyelitis (CRMO): Presentation, Pathogenesis, and Treatment



Current Osteoporosis Reports 15(6): 542-554



Chronic non-bacterial osteomyelitis (CNO) with its most severe form chronic recurrent multifocal osteomyelitis (CRMO) is an autoinflammatory bone disorder. We summarize the clinical presentation, diagnostic approaches, most recent advances in understanding the pathophysiology, and available treatment options and outcomes in CNO/CRMO. Though the exact molecular pathophysiology of CNO/CRMO remains somewhat elusive, it appears likely that variable defects in the TLR4/MAPK/inflammasome signaling cascade result in an imbalance between pro- and anti-inflammatory cytokine expressions in monocytes from CNO/CRMO patients. In this context, we present previously unpublished data on cytokine and chemokine expression in monocytes and tissues. CNO/CRMO is an autoinflammatory bone disorder resulting from imbalanced cytokine expression from innate immune cells. Though the exact molecular pathophysiology remains unclear, variable molecular defects appear to result in inflammasome activation and pro-inflammatory cytokine expression in monocytes from CNO/CRMO patients. Recent advances suggest signaling pathways and single molecules as biomarkers for CNO/CRMO as well as future treatment targets.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059500759

Download citation: RISBibTeXText

PMID: 29080202

DOI: 10.1007/s11914-017-0405-9


Related references

Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO). Plos one 12(3): E0169687, 2017

Etanercept treatment in five cases of refractory chronic recurrent multifocal osteomyelitis (CRMO). Joint Bone Spine 82(6): 471-473, 2015

Chronic recurrent multifocal osteomyelitis (CRMO). Rofo 168(2): 115-127, 1998

Chronic recurrent multifocal osteomyelitis (CRMO). Jbr-Btr 91(3): 92-93, 2008

Chronic recurrent multifocal osteomyelitis (CRMO). European Journal of Pediatric Surgery 6(1): 45-51, 1996

Vertebral manifestation of chronic recurrent multifocal osteomyelitis (CRMO). Rofo 174(10): 1236-1242, 2002

Chronic recurrent multifocal osteomyelitis crmo a review of seven cases. Arthritis and Rheumatism 30(4 Suppl.): S80, 1987

Chronic recurrent multifocal osteomyelitis (CRMO) - advancing the diagnosis. Pediatric Rheumatology Online Journal 14(1): 47, 2016

Musculoskeletal case of the day. Chronic recurrent multifocal osteomyelitis (CRMO). Ajr. American Journal of Roentgenology 169(1): 285 289-91, 1997

Mandibular involvement in chronic recurrent multifocal osteomyelitis (CRMO) in adulthood. Mund- Kiefer- und Gesichtschirurgie 4(3): 187-192, 2000

Technetium 99m mdp bone imaging in chronic recurrent multifocal osteomyelitis crmo. Journal of Nuclear Medicine 31(5 Suppl.): 938-939, 1990

Physeal and epiphyseal involvement in chronic recurrent multifocal osteomyelitis (CRMO). Pediatric Radiology 20(7): 570, 1990

Chronic pain in both thighs. Chronic recurrent multifocal osteomyelitis (CRMO). Der Radiologe 41(8): 701-704, 2001

Serum biomarkers for the diagnosis and monitoring of chronic recurrent multifocal osteomyelitis (CRMO). Rheumatology International 36(6): 769-779, 2016

SAT0260A Novel MRI-Based Analysis Workflow for Chronic Recurrent Multifocal Osteomyelitis (CRMO). Annals of the Rheumatic Diseases 75(Suppl 2): 762.3-763, 2016